bluuebunny/crossref_metadata_2025_split huggingface dataset:
The English national health service diabetes prevention programme (NHS DPP): A scoping review of existing evidence
Authors: Whelan Maxine , Bell Lauren 
Published: April 2022

AbstractAimsThe English National Health Service Diabetes Prevention Programme (NHS DPP) is commissioned by NHS England and has been rolled out across England to adults identified as being at high risk of type 2 diabetes. The present scoping review aimed to identify the extent and nature of evidence to date on the NHS DPP and describe what the evidence has reported.MethodsA scoping review involving searches of various sources (including MEDLINE, CINAHL, MediArXiv, Google Scholar and GreyLit) was conducted on 31 August 2021 and repeated on 09 February 2022. Only articles reporting on the NHS DPP made available since 2015 were eligible for inclusion.Results65 articles were included. Of these, 37 were journal publications. Most articles were made available in 2018 and 2020 (totaln = 25). The majority of articles reported on uptake and retention (n = 27) whilst others reported on implementation considerations (n = 24), programme outcomes (n = 21), stakeholder experience (n = 8) and screening and referral processes (n = 3). Various research methods were reported and included qualitative (n = 9) and document analysis (n = 8). Articles revealed preliminary evidence on service user characteristics, rates of referral, uptake and retention as well as how far the NHS DPP is being delivered in line with its evidence base and service specification.ConclusionsThe evidence is accumulating on NHS DPP uptake and retention most, with emerging evidence on programme outcomes (such as weight loss and HbA1c). More evidence is warranted on stakeholder experience to decipher how to overcome low initial and long‐term engagement reported by the current evidence base.
The effects of empagliflozin, dietary energy restriction, or both on appetite‐regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The SEESAW randomized, double‐blind, placebo‐controlled trial
Authors: Sargeant Jack A. , King James A. , Yates Thomas , Redman Emma L. , Bodicoat Danielle H. , Chatterjee Sudesna , Edwardson Charlotte L. , Gray Laura J. , Poulin Benoit , Waheed Ghazala , Waller Helen L. , Webb David R. , Willis Scott A. , Wilding John P. H. , Khunti Kamlesh , Stensel David J. , Davies Melanie J. 
Published: April 2022

AbstractAimTo assess the impact of the sodium‐glucose co‐transporter‐2 (SGLT2) inhibitor empagliflozin (25 mg once‐daily), dietary energy restriction, or both combined, on circulating appetite‐regulatory peptides in people with type 2 diabetes (T2D) and overweight or obesity.Materials and MethodsIn a double‐blind, placebo‐controlled trial, 68 adults (aged 30‐75 years) with T2D (drug naïve or on metformin monotherapy; HbA1c 6.0%‐10.0% [42‐86 mmol/mol]) and body mass index of 25 kg/m2 or higher were randomized to (a) placebo only, (b) placebo plus diet, (c) empagliflozin only or (d) empagliflozin plus diet for 24 weeks. Dietary energy restriction matched the estimated energy deficit elicited by SGLT2 inhibitor therapy through urinary glucose excretion (~360 kcal/day). The primary outcome was change in postprandial circulating total peptide‐YY (PYY) during a 3‐hour mixed‐meal tolerance test from baseline to 24 weeks. Postprandial total glucagon‐like peptide‐1 (GLP‐1), acylated ghrelin and subjective appetite perceptions formed secondary outcomes, along with other key components of energy balance.ResultsThe mean weight loss in each group at 24 weeks was 0.44, 1.91, 2.22 and 5.74 kg, respectively. The change from baseline to 24 weeks in postprandial total PYY was similar between experimental groups and placebo only (mean difference [95% CI]: −8.6 [−28.6 to 11.4], 13.4 [−6.1 to 33.0] and 1.0 [−18.0 to 19.9] pg/ml in placebo‐plus diet, empagliflozin‐only and empagliflozin‐plus‐diet groups, respectively [all P ≥ .18]). Similarly, there was no consistent pattern of difference between groups for postprandial total GLP‐1, acylated ghrelin and subjective appetite perceptions.ConclusionsIn people with T2D and overweight or obesity, changes in postprandial appetite‐regulatory gut peptides may not underpin the less than predicted weight loss observed with empagliflozin therapy.Clinical Trials RegistrationNCT02798744, www.ClinicalTrials.gov; 2015‐001594‐40, www.EudraCT.ema.europa.eu; ISRCTN82062639, www.ISRCTN.org.
A randomized pharmacokinetic and pharmacodynamic trial of two regular human insulins demonstrates bioequivalence in type 1 diabetes and availability of biosimilar insulin may improve access to this medication
Authors: Vencio Sérgio , Caiado‐Vencio Rafael , Caixeta Leonardo Ferreira , Masierek Małgorzata , Mlynarski Wojciech , Drzewoski Józef , Gregory Justin M. 
Published: April 2022

AbstractAimsTo compare the pharmacokinetic (PK) and pharmacodynamic (PD) effects and safety of therapeutic dosages of a regular insulin (experimental drug) produced by Bioton S.A. (Warsaw, Poland) versus Humulin® R, a regular insulin (reference drug) produced by Eli Lilly (Indianapolis, Indiana).Materials and MethodsIn a single‐centre, randomized, double‐blinded phase 1 crossover study, we used the manual euglycaemic clamp technique to compare PK and PD profiles between single subcutaneous doses (0.3 units/kg) of the two regular insulins in participants with type 1 diabetes (T1DM) with a washout period of 14 (± 7) days between tests.ResultsWe evaluated 56 participants. The mean participant age and body mass index were 32.9 years and 22.9 kg/m2, respectively. The ratios (experimental/reference) of the geometric means of maximum plasma insulin concentration and for plasma insulin area under the curve (AUC) were 0.909 (90% confidence interval [CI] 0.822‐1.01) and 0.993 (90% CI 0.944‐1.04), respectively. The ratios of the geometric means of maximum glucose infusion rate (GIR) and for GIR AUC were 0.999 (95% CI 0.912‐1.09) and 1.04 (95% CI 0.962‐1.12), respectively.ConclusionsThe experimental product regular human insulin and comparator Humulin® R are bioequivalent in patients with T1DM. Wider entry to the pharmaceutical market of affordable, biosimilar regular insulins may substantially improve access to insulin for many socioeconomically disadvantaged patients with diabetes.
Linguistic capital and status: The interaction between language skills, personal reputation, and perceived collaboration performance
Authors: Lauring Jakob , Vulchanov Ivan Olav , Stoermer Sebastian 
Published: April 2022

AbstractAlthough language has become a central theme in international business and management research, this stream still holds many unexplored research avenues. One area that has attracted some attention, but lacks extensive systematic assessment, is the connection between language and personal reputation. Qualitative research has offered tentative insights suggesting that proficiency in key organizational languages increases the status of individuals over and above their functional abilities. In this study, we use data from 171 pairs of expatriate academics and their local academic collaboration partners. We asked the local academic peers to rate expatriate academics' reputation, their local and English language skills, and collaboration performance. As expected, we found a positive association between academic reputation and collaboration performance. In line with analyses from qualitative research, we show a moderation effect of language skills, where high common organizational language (English) proficiency compensates for a weaker perceived reputation in predicting collaboration performance. Surprisingly, however, there was no moderating effect of local language skills.
A randomized, double‐blind trial of triheptanoin for drug‐resistant epilepsy in glucose transporter 1 deficiency syndrome
Authors: Striano Pasquale , Auvin Stéphane , Collins Abigail , Horvath Rita , Scheffer Ingrid E. , Tzadok Michal , Miller Ian , Kay Koenig Mary , Lacy Adrian , Davis Ronald , Garcia‐Cazorla Angela , Saneto Russell P. , Brandabur Melanie , Blair Susan , Koutsoukos Tony , De Vivo Darryl 
Published: April 2022

AbstractObjectiveThis study was undertaken to evaluate efficacy and long‐term safety of triheptanoin in patients >1 year old, not on a ketogenic diet, with drug‐resistant seizures associated with glucose transporter 1 deficiency syndrome (Glut1DS).MethodsUX007G‐CL201 was a randomized, double‐blind, placebo‐controlled trial. Following a 6‐week baseline period, eligible patients were randomized 3:1 to triheptanoin or placebo. Dosing was titrated to 35% of total daily calories over 2 weeks. After an 8‐week placebo‐controlled period, all patients received open‐label triheptanoin through Week 52.ResultsThe study included 36 patients (15 children, 13 adolescents, eight adults). A median 12.6% reduction in overall seizure frequency was observed in the triheptanoin arm relative to baseline, and a 13.5% difference was observed relative to placebo (p = .58). In patients with absence seizures only (n = 9), a median 62.2% reduction in seizure frequency was observed in the triheptanoin arm relative to baseline. Only one patient with absence seizures only was present in the control group, preventing comparison. No statistically significant differences in seizure frequency were observed. Common treatment‐emergent adverse events included diarrhea, vomiting, abdominal pain, and nausea, mostly mild or moderate in severity. No serious adverse events were considered to be treatment related. One patient discontinued due to status epilepticus.SignificanceTriheptanoin did not significantly reduce seizure frequency in patients with Glut1DS not on the ketogenic diet. Treatment was associated with mild to moderate gastrointestinal treatment‐related events; most resolved following dose reduction or interruption and/or medication for treatment. Triheptanoin was not associated with any long‐term safety concerns when administered at dose levels up to 35% of total daily caloric intake for up to 1 year.
Seizure forecasting using minimally invasive, ultra‐long‐term subcutaneous EEG: Generalizable cross‐patient models
Authors: Pal Attia Tal , Viana Pedro F. , Nasseri Mona , Duun‐Henriksen Jonas , Biondi Andrea , Winston Joel S. , P. Martins Isabel , Nurse Ewan S. , Dümpelmann Matthias , Worrell Gregory A. , Schulze‐Bonhage Andreas , Freestone Dean R. , Kjaer Troels W. , Brinkmann Benjamin H. , Richardson Mark P. 
Published: April 2022

AbstractThis study describes a generalized cross‐patient seizure‐forecasting approach using recurrent neural networks with ultra‐long‐term subcutaneous EEG (sqEEG) recordings. Data from six patients diagnosed with refractory epilepsy and monitored with an sqEEG device were used to develop a generalized algorithm for seizure forecasting using long short‐term memory (LSTM) deep‐learning classifiers. Electrographic seizures were identified by a board‐certified epileptologist. One‐minute data segments were labeled as preictal or interictal based on their relationship to confirmed seizures. Data were separated into training and testing data sets, and to compensate for the unbalanced data ratio in training, noise‐added copies of preictal data segments were generated to expand the training data set. The mean and standard deviation (SD) of the training data were used to normalize all data, preserving the pseudo‐prospective nature of the analysis. Different architecture classifiers were trained and tested using a leave‐one‐patient‐out cross‐validation method, and the area under the receiver‐operating characteristic (ROC) curve (AUC) was used to evaluate the performance classifiers. The importance of each input signal was evaluated using a leave‐one‐signal‐out method with repeated training and testing for each classifier. Cross‐patient classifiers achieved performance significantly better than chance in four of the six patients and an overall mean AUC of 0.602 ± 0.126 (mean ± SD). A time in warning of 37.386% ± 5.006% (mean ± std) and sensitivity of 0.691 ± 0.068 (mean ± std) were observed for patients with better than chance results. Analysis of input channels showed a significant contribution (p < .05) by the Fourier transform of signals channels to overall classifier performance. The relative contribution of input signals varied among patients and architectures, suggesting that the inclusion of all signals contributes to robustness in a cross‐patient classifier. These early results show that it is possible to forecast seizures training with data from different patients using two‐channel ultra‐long‐term sqEEG.
Identifying subcutaneous tissue microcalcification by Fluo‐3 AM imaging in cutaneous calciphylaxis
Authors: Zhu Xiaodong , Liu Yuqiu , Yang Xin , Liu Bicheng , Zhang Xiaoliang 
Published: April 2022

AbstractCalciphylaxis, also known as calcific uremic arteriolopathy (CUA), is typically characterized by subcutaneous tissue calcification and excruciatingly painful cutaneous lesions with high mortality. It is critical for dermatologists to make early diagnosis and appropriate management, yet currently only 56% of calciphylaxis cases are correctly diagnosed by conventional histological stain1. Specially, the identification of subtle calcium deposits of subcutaneous can be challenging but is believed crucial for early diagnosis of calciphylaxis2. More sensitive calcification staining is in high demand. In this study, Fluo‐3 AM was found to be a rapid, sensitive and reliable fluorescent probe for the detection of calcium deposits and could be a promising diagnostic tool for calciphylaxis.
A thermomechanical constitutive model for investigating the fatigue behavior of Sn‐rich solder under thermal cycle loading
Authors: Zhang Zhao , Liu Sheng , Ma Kun , Shi Tielin , Qian Zhengfang , Liang Kang , Dong Fang 
Published: April 2022

AbstractBased on crystal plastic theory, a novel thermomechanical constitutive model was proposed for Sn‐rich solder. Material parameters of the proposed constitutive model were determined by fitting the stress–strain curves under uniaxial tensile testings. Combined with the proposed model and the material parameters, crystal plastic finite element method was used to investigate the effects of the microstructure features of grain orientation, grain boundary, and intermetallic compound on the fatigue behaviors of Sn‐rich solder joint under the condition of thermal cycle loading. Results showed that the mean absolute percentage error between the simulation and experimental tensile curves was 3.50%, and the three microstructure features affected the fatigue behaviors of Sn‐rich solder from different aspects, which were analyzed in detail. Besides, it was concluded that the proposed constitutive model could be effectively used to investigate the fatigue behaviors of Sn‐rich solder joint from micro perspective.
Alpha and beta diversity and species co‐occurrence patterns in headwaters supporting rare intermittent‐stream specialists
Authors: Aspin Thomas , House Andy 
Published: April 2022

Abstract

Intermittent rivers are the focus of a burgeoning subdiscipline of freshwater science, driven by mounting recognition of their ubiquity, biodiversity, and climate sensitivity. However, our understanding of their ecology is hampered by a reliance on unstandardised diversity measures, an underrepresentation of certain stream types in metacommunity research and a reticence to acknowledge biotic interactions as a potentially fundamental driver of catchment‐scale patterns in assemblage composition.

This study analysed both local‐ and catchment‐scale responses of invertebrates to flow intermittence and hydrological isolation in an understudied ecosystem type (low‐gradient, groundwater‐fed headwaters). We compared responses of conventional (taxonomic richness, Shannon diversity) and more robust (coverage‐adjusted Hill–Shannon) α‐diversity metrics to drying, and analysed changes in β‐diversity components as a function of hydrological and spatial distances between samples. We also inferred the influence of biotic interactions on metacommunity structure, using hierarchical species distribution modelling to capture species‐to‐species associations after accounting for hydrological variability and dispersal traits.

The conventional and robust α‐diversity metrics exhibited broadly similar shifts, although richness overestimated the decline in α‐diversity with intermittence and the Shannon index failed to detect a significant interaction between flow duration and hydrological isolation. Decomposition of β‐diversity revealed a dominance of species turnover over nestedness along the flow gradient, a finding contrary to prevailing conceptual wisdom in intermittent river ecology and one we attribute to the climatic and geological context of our study.

Even after accounting for differences in hydrological niche occupation, we discovered a significant propensity for species to co‐occur with others of similar conservation status, implying that competition/colonisation trade‐offs involving rare specialists and widespread generalists could underpin metacommunity assembly in some drying headwater networks.

Our results suggest that enhancing aquatic habitat connectivity in headwaters harbouring intermittent‐stream specialists could be counterproductive, and conservation plans should instead look to safeguard isolated habitats serving as biotic refuges for rare species.
Identifying climate refugia for high‐elevation Alpine birds under current climate warming predictions
Authors: Brambilla Mattia , Rubolini Diego , Appukuttan Ojan , Calvi Gianpiero , Karger Dirk Nikolaus , Kmecl Primož , Mihelič Tomaž , Sattler Thomas , Seaman Benjamin , Teufelbauer Norbert , Wahl Johannes , Celada Claudio 
Published: April 2022

AbstractIdentifying climate refugia is key to effective biodiversity conservation under a changing climate, especially for mountain‐specialist species adapted to cold conditions and highly threatened by climate warming. We combined species distribution models (SDMs) with climate forecasts to identify climate refugia for high‐elevation bird species (Lagopus muta, Anthus spinoletta, Prunella collaris, Montifringilla nivalis) in the European Alps, where the ecological effects of climate changes are particularly evident and predicted to intensify. We considered future (2041–2070) conditions (SSP585 scenario, four climate models) and identified three types of refugia: (1) in‐situ refugia potentially suitable under both current and future climate conditions, ex‐situ refugia suitable (2) only in the future according to all future conditions, or (3) under at least three out of four future conditions. SDMs were based on a very large, high‐resolution occurrence dataset (2901–12,601 independent records for each species) collected by citizen scientists. SDMs were fitted using different algorithms, balancing statistical accuracy, ecological realism and predictive/extrapolation ability. We selected the most reliable ones based on consistency between training and testing data and extrapolation over distant areas. Future predictions revealed that all species (with the partial exception of A. spinoletta) will undergo a range contraction towards higher elevations, losing 17%–59% of their current range (larger losses in L. muta). We identified ~15,000 km2 of the Alpine region as in‐situ refugia for at least three species, of which 44% are currently designated as protected areas (PAs; 18%–66% among countries). Our findings highlight the usefulness of spatially accurate data collected by citizen scientists, and the importance of model testing by extrapolating over independent areas. Climate refugia, which are only partly included within the current PAs system, should be priority sites for the conservation of Alpine high‐elevation species and habitats, where habitat degradation/alteration by human activities should be prevented to ensure future suitability for alpine species.
Changes in patient activation in people starting dialysis: A prospective longitudinal, observational study
Authors: Hussein Wael F. , Bennett Paul N. , Carrasco Anna , Sun Sumi , Reiterman Marc , Watson Emily , Schiller Brigitte 
Published: April 2022

AbstractIntroductionIncreased patient activation is associated with improved health outcomes; however, little is known about patient activation in people with end‐stage kidney disease at the start of their dialysis journey. This study aimed to measure activation status changes over the first 4 months of dialysis.MethodsProspective, longitudinal, and observational study. Incident patients initiating dialysis at 25 in‐center hemodialysis and 17 home dialysis programs across three US states managed by the same dialysis provider completed the 13‐item Patient Activation Measure (PAM‐13) survey at baseline (month 1 after commencement of dialysis) and follow‐up (month 4). The survey yields a score (0–100) that corresponds to four levels (1–4), with higher scores or levels indicating higher activation.FindingsOne hundred eighty‐two participants (139 center, 43 home) completed both baseline and follow‐up surveys. Mean age was 60 ± 15 years, 40% female. Mean PAM‐13 scores were 65.1 ± 16.8 and 64.8 ± 17.8 at baseline and follow‐up, respectively; mean intraindividual change: −0.3 ± 17.3. The proportions of patients at levels 1–4 at baseline were 11%, 23%, 35%, and 31% respectively. At follow‐up, 50%, 64%, 52%, and 37% of participants at levels 1–4, respectively, changed to a different PAM level (Spearman correlation = 0.47; p < 0.001). Home dialysis was associated with higher PAM scores when compared to in‐center hemodialysis in multivariable analyses, adjusted for sociodemographic variables, comorbidities, and predialysis nephrology care (β = 5.74, 95% confidence intervals [CI]: 0.11–11.37 and 9.02, 95% CI: 3.03–15.02, at baseline and follow–up, respectively).DiscussionAlthough aggregated group scores and levels remained stable, intra‐individual patient activation changed significantly during the first 4 months of dialysis. This novel finding is foundational to future projects aiming to design interventions to improve patient activation.
Comparison of topical sucralfate with dexpanthenol in rat wound model
Authors: Yildizhan Eda , Ulger Burak Veli , Akkus Murat , Akinci Dilara , Basol Omer 
Published: April 2022

AbstractWound healing is a dynamic process initiated in response to injury. There are many factors that have detrimental effects on the wound healing process. Numerous studies have been conducted for improving wound healing processes. Dexpanthenol is widely used to accelerate wound healing. Sucralfate is used for the treatment of peptic ulcers. We aimed to compare the efficacy of topical Dexpanthenol and Sucralfate in an experimental wound model in rats via histopathological examinations and immune histochemical determinations, as well, to evaluate their effects on EGF levels. Three different groups were formed: the Control Group, the Dexpanthenol Group and the Sucralfate Group. Full‐thickness skin wounds were created on the back of each rat and isotonic saline was applied to the wounds of the rats in the control group, Bepanthol® cream was applied in Dexpanthenol Group and 10% Sucralfate cream was applied in Sucralfate Group, once a day. On the 7th, 14th and 21st days the wounds were measured and seven rats from each group were sacrificed and the wounds were excised for histopathological examination. Sucralfate increased wound healing rates by increasing neovascularization, fibroblast activation, reepithelialization and collagen density, as well as dexpanthenol. Our study revealed that the dexpanthenol and sucralfate groups were better than the control group in terms of their effects on wound healing, however there was no statistically significant difference among these two groups. Sucralfate improves EGF expression in skin wounds and has positive results on skin wound healing comparable to dexpanthenol.